L310-0899 Screening compound: 6-chloro-4-[(5-cyclopropyl-1,2,4-oxadiazol-3-yl)methyl]-3-oxo-N-[(oxolan-2-yl)methyl]-3,4-dihydro-2H-1,4-benzoxazine-7-sulfonamide

L310-0899 Screening compound: 6-chloro-4-[(5-cyclopropyl-1,2,4-oxadiazol-3-yl)methyl]-3-oxo-N-[(oxolan-2-yl)methyl]-3,4-dihydro-2H-1,4-benzoxazine-7-sulfonamide
L310-0899 Screening compound: 6-chloro-4-[(5-cyclopropyl-1,2,4-oxadiazol-3-yl)methyl]-3-oxo-N-[(oxolan-2-yl)methyl]-3,4-dihydro-2H-1,4-benzoxazine-7-sulfonamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L310-0899
6-chloro-4-[(5-cyclopropyl-1,2,4-oxadiazol-3-yl)methyl]-3-oxo-N-[(oxolan-2-yl)methyl]-3,4-dihydro-2H-1,4-benzoxazine-7-sulfonamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L310-0899

Molecular Formula

C19H21ClN4O6S (C19 H21 ClN4 O6 S)

Compound Name

6-chloro-4-[(5-cyclopropyl-1,2,4-oxadiazol-3-yl)methyl]-3-oxo-N-[(oxolan-2-yl)methyl]-3,4-dihydro-2H-1,4-benzoxazine-7-sulfonamide

IUPAC name

6-chloro-4-[(5-cyclopropyl-124-oxadiazol-3-yl)methyl]-3-oxo-N-[(oxolan-2-yl)methyl]-34-dihydro-2H-14-benzoxazine-7-sulfonamide

SMILES

O=C(COc1c2)N(Cc3noc(C4CC4)n3)c1cc(Cl)c2S(NCC1OCCC1)(=O)=O

InChI

InChI=1S/C19H21ClN4O6S/c20-13-6-14-15(7-16(13)31(26,27)21-8-12-2-1-5-28-12)29-10-18(25)24(14)9-17-22-19(30-23-17)11-3-4-11/h6-7,11-12,21H,1-5,8-10H2/t12-/m1/s1

InChI Key

OPNRZMGIZARZAB-GFCCVEGCSA-N

MDL Number (MFCD)

MFCD27244367

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

468.92

Hydrogen Bond Acceptors Count

12.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

1.931

Distribution Coefficient, logD

1.931

Water Solubility, LogSw

-2.91

Polar Surface Area

107.672

Acid Dissociation Constant (pKa)

11.46

Base Dissociation Constant (pKb)

-2.81

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

52.60

L310-0899 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

GPCR Targeted Library (31838 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

New Agro Library (44492 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
Targets:
  • GPCR
  • Others
Mechanism of action:
  • Receptor's ligands
  • Epigenetic
Agro:
  • Agro

References: we are preparing a list of scientific research reports with L310-0899 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L310-0899?
Check Price and Availability of L310-0899, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L310-0899 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L310-0899
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L310-0899
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L310-0899 available by request